NBI 35965 hydrochloride
NBI 35965 hydrochloride is a selective, orally active and brain-penetrant corticotropin-releasing factor receptor 1 (CRF1) antagonist with a Ki value of 4 nM and a pKi value of 8.5. NBI 35965 hydrochloride does not inhibit CRF2. NBI 35965 hydrochloride reduces CRF or stress-induced adrenocorticotropic hormone (ACTH) production in vivo with pIC50 values of 7.1 and 6.9, respectively. NBI 35965 hydrochloride shows anxiolytic effects.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 1782228-59-4
- 分子式: C21H23Cl3N4
- 分子量:437.79
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
|
CRFR1 4 nM (Ki) |
CRFR1 8.5 (pKi) |
NBI 35965 hydrochloride displays a high affinity for CRF1 while having no binding affinity to CRF2. NBI 35965 hydrochloride also inhibits the stimulation of cAMP induced by Sauvagine in CRF1 transfected cells[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
In rats, NBI 35965 hydrochloride (Compound 12a; 10 mg/kg) has a volume of distribution 17.8 L/kg, a plasma clearance of 17 mL/min/kg, and a half-life of 12 h. The estimated oral bioavailability is 34% with a mean maximal plasma concentration at 1 h of 560 ng/mL. NBI 35965 hydrochloride also penetrated the blood-brain barrier, resulting in a mean maximal brain concentration of 700 ng/g[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Male CD-1 mice (24-26 g) bearing restraint stress[1]
-
Dosage:20 mg/kg (10 mL/kg 5% mannitol-d (w/v) in water)
-
Administration:Oral gavage; 60 min prior to the initiation of the stressor
-
Result:Reduced stress induced ACTH production in vivo.
化学情報
-
CAS 番号 1782228-59-4
-
分子量 437.79
-
分子式 C21H23Cl3N4
-
SMILES
CC[C@H]1CN2N=C(C3=C(C=C(C=C3)Cl)Cl)C4=NC(C)=CC(N1CC5CC5)=C42.Cl
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
[1]. Gross RS, et al. Design and synthesis of tricyclic corticotropin-releasing factor-1 antagonists. J Med Chem. 2005 Sep 8;48(18):5780-93. [Content Brief]
[2]. Mulugeta Million, et al. A novel water-soluble selective CRF1 receptor antagonist, NBI 35965, blunts stress-induced visceral hyperalgesia and colonic motor function in rats. Brain Res. 2003 Sep 19;985(1):32-42. [Content Brief]
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)